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1  The inflammasome
The inflammasome is a multi-protein macromolecular 
signalling complex that utilises induced proximity [1] to 
induce caspase-1 activation and subsequent processing 
of the proinflammatory cytokines pro-interleukin 
(IL)-1β and pro-IL-18 to their active forms [2–4] (Box 1). 
Inflammasomes form as a result of activation of specific 
cytosolic pattern recognition receptors that include 
members of the nucleotide-binding domain, and leucine-
rich repeat containing receptor (NLR) family such as 
NLRP1 (NLR family, pyrin domain containing 1), NLRP3, 
NAIP (Neuronal apoptosis inhibitory protein), NLRC4 
(NLR family, CARD (caspase recruitment domain) domain 
containing 4), as well as Pyrin and AIM2 (Absent in 
melanoma 2) (Box 1) (Figure 1A & B). Inflammasome-
forming receptors all contain N-terminal effector domains 
from the death domain superfamily (Box 1) (Figure 1A & 
B). These effector domains are crucial for mediating the 
protein-protein contacts required for complex formation 
and downstream signalling and processing events. Prior 
to activation the receptors exist in an autoinhibited state 
in the resting cell. However, following activation the 
receptor undergoes conformational changes which result 
in protein aggregation and cause the effector domains to 
become available for further interactions, for example 
with the adaptor protein ASC (apoptosis-associated 
speck-like protein containing a CARD) . This results in 
the rapid formation of a large, up to two microns wide, 
‘speck’-like structure in the cytosol of the cell (Box 1). The 
overall composition of the speck remains something of 
an enigma, but it can be broadly described as consisting 
of the activated receptor, the adaptor protein ASC, and 
inflammatory caspases such as caspase-1, caspase-5 
and caspase-8 [2–4] (Figure 1B). Formation of the speck 
is driven by rapid self-association of the adaptor protein 
ASC, most likely with the activated receptor serving 
as a nucleation centre [5]. In the case of the NLRC4 
inflammasome this occurs less than five minutes after 
receptor activation [6]. Inflammasome formation is a 
central component of the cellular response to damage 
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Box 1: Key definitions
Adaptor protein - A protein that links two other functional proteins in a multiprotein complex. In the case of the inflammasome ASC acts as 
an adaptor protein by mediating the recruitment of the caspases to the activated receptor. ASC possesses both pyrin and caspase recruit-
ment domains so mediates these interactions via interactions between death domain family members. 
Death domain - A helical protein fold commonly found mediating multiprotein interactions in large protein complexes formed in inflammato-
ry and death signalling pathways. The death domain superfamily contains four members: the death domain, the death effector domin, the 
pyrin domain, and the caspase recruitment domain. 
Effector domain - A protein domain found in the initiating receptor that is involved in mediating further protein-protein interactions to either 
aid the formation of a multiprotein complex, or initiate protein signalling or catalytic processing cascades. In the inflammasome the pyrin 
and caspase recruitment domains of the NLR or AIM2 proteins function as effector domains. 
Induced Proximity - When certain catalytic proteins, such as caspases, are brought into close enough proximity through binding to other 
cellular proteins they are able to become activated either as a result of auto-proteolysis, or through proteolytic cleavage by a near neigh-
bour. 
Inflammasome forming receptors - Cytosolic pattern recognition receptors (such as NLRP1, NLRP3, NLRC4 and AIM2) that when activated 
lead to the recruitment of ASC, the formation of a large multiprotein complex (speck) and result in the activation of caspases which in turn 
process the inflammatory cytokine precursors pro-IL-1β and pro-IL-18. 
Speck - Large macromolecular complex (upto 2 microns diameter) formed upon the activation of inflammasome forming receptors and 
driven by the oligomerisation of ASC.
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Figure 1: General architecture and organisation of the inflammasome. (A) Domain architecture of the major inflammasome forming pattern 
recognition receptors and apoptosome forming proteins from humans and Caenorhabditis elegans. (B) Schematic representation of the 
constituents of the NLRP1, NLRP3, NLRC4 and AIM2 inflammasomes. In both panels domains are coloured as follows: Pyrin (PYD) - pink; 
CARD - red; NBD /NB-ARC - blue, LRR/WD40 - grey. In addition in panel B the caspase catalytic domains are coloured cyan. Effector domains 
that mediate protein:protein interaction are are represented by the PYD and CARD domains.
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and threat. However, inappropriate and deregulated 
inflammasome activation can lead to the development 
of multiple diseases including gout, atherosclerosis and 
autoinflammatory disorders [7]. Of critical importance 
in inflammatory disease is the central role of the 
inflammasome in generating IL-1β, which along with 
IL-1α, can be viewed as a master cytokine in the control 
and regulation of both local and systemic inflammation. 
This importance is exemplified by the success of the 
interleukin-1 blocking therapies anakinra, rilonacept and 
canakinumab for the treatment of chronic inflammatory 
conditions [8]. Consequently, a full understanding of the 
global inflammasome structure and how it functions will 
be an important part of delineating the aetiology of, and 
developing new treatments for, these diseases.  
2  Is the inflammasome structurally 
comparable to the apoptosome?
Based on similarities between the domain organisation of 
the NLR family and Apaf-1 (Apoptotic protease-activating 
factor 1; Figure 1) it has long been assumed that the 
inflammasome will adopt a similar conformation to the 
apoptosis-inducing apoptosome formed by Apaf-1 and 
procaspase-9 and other apoptosome forming proteins 
[9] (Figure 2A). Electron Microscopy (EM) of purified 
preparations of NLRP1 and NLRC4/NAIP has shown 
these proteins to be capable of forming comparable in 
vitro wheel-like structures with an approximate diameter 
of between 15 and 30 nm [10,11]. Unlike the apoptosome 
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Figure 2: Structural and schematic representations of death domain superfamily complexes. (A) Orthologues of Apaf-1 from Drosophila 
melanogaster and Caenorhabditis elegans form wheel-like apoptosomes. Structure of a single-ring, DARK apoptosome showing the CARDs 
resting on top of an octomeric ring of NB-ARC domains, surrounded by WD40 domains (left panel; adapted from PDB 1VT4). Model of an 
octomeric CED4 apoptosome showing the CARDs forming a disc above the NB-ARC domains (generated using four dimeric molecules (PDB 
3LQR) superimposed on the DARK apoptosome octomer (PDB 1VT4) (right panel). (B) The structural (left panel) and schematic (right panel) 
organisation of seven death domains taken from the MyD88 crystal structure (Myddosome). The central death domain (red) is surrounded by 
six others: those in orange bind through type I interactions, those in blue bind through type II interactions and those in yellow bind through 
type III interactions. The type of interface is labelled on the schematic representation.
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the stoichiometry of these “inflammasomes” is less 
well defined, consisting of either 5 to 7 (NLRP1) or, 11 or 
12 (NLRC4/NAIP) protomers each. This variability may 
explain why these structures have yet to be successfully 
crystallised, and as yet their physiological relevance 
cannot be confirmed. However, recent molecular 
modelling studies have demonstrated that the CARD of 
ASC would be able to adopt a conformation compatible 
with such structural arrangements [12]. Other, non-
inflammasome forming NLR proteins, such as NLRC5, 
have been successfully modelled onto a heptameric 
apoptosome framework [13]. Whether the inflammasome 
forms such a complex within the cell, or indeed if it does 
how these then assemble to ultimately create a super-
structure with a diameter more than 30-times that of an 
individual wheel remains to be determined.
In addition to the comparisons made to the 
apoptosome, macromolecular structures from the death 
domain (DD) superfamily, such as the PIDD (p53-induced 
death domain protein)-osome [14] and Myddosome [15], 
have helped drive mutagenic studies investigating the 
protein-protein interactions involved in inflammasome 
formation (Figure 2B). Although the components of the 
inflammasome do not contain death domains, they do 
possess Pyrin (PYD) and CARD motifs which are members 
of the DD superfamily. The PIDDosome and Myddosome 
structures have allowed three separate interaction 
interfaces (Types I, II and III) to be described. The interfaces 
function as key sites of contact in the protein-protein 
interactions required for assembly of the macromolecular 
complex. Collectively, these interfaces allow each 
death domain to interact with six others, mediating the 
formation of macromolecular structures (Figure 2B). The 
behaviour, role and importance of these interfaces is neatly 
reviewed in a recent paper by Kersse and Vandenabeele 
[16]. Consistent with a similar method of interaction 
disruption of the proposed interface residues in the PYD 
and CARD domains of the inflammasome has enabled 
the identification of key functional residues involved in 
complex formation. These include: a hydrophobic patch 
on the AIM2 PYD [17]; residues R10, D27, E41, K42, R55 and 
D59 of the caspase-1 CARD [18,19]; E14, R42, R75 and R80 
in the Pyrin PYD; and multiple amino acids in both the 
PYD (E13, K21, R41, D48, D51) and CARD (R125, E130, D134, 
Y137, E144, R160, D191) of ASC [19,20]. Without question it 
has become apparent that the key inflammasome forming 
protein, ASC, uses more than one protein interface to 
engage more than one binding partner simultaneously 
during inflammasome formation [19–21]
3  Molecular structures of inflamma-
some components
The molecular structure of an increasing number of the 
components of the inflammasome has been resolved. 
These include: the PYD of NLRP1 (PDB 1PN5), NLRP3 (PDB 
3QF2), AIM2 (PDBs 4O7Q, 3VD8), ASC (PDBs 1UCP, 3J63) 
and Pyrin (PDB 2MPC) [17,20,22–26]; the  CARD of NLRP1 
(PDBs 4IFP, 3KAT) [27]; full-length ASC (PDB 2KN6) [28]; the 
auto-inhibited NLRC4 NBD (nucleotide-binding domain) 
and leucine rich repeats (LRR) (PDB 4KXF) [29]; the LRRs 
of NLRP1 (PDB 4IM6) [30]; and the HIN (hematopoietic 
interferon-inducible nuclear localization) domain of AIM2 
in complex with dsDNA (PDBs 3RN2, 3RN5, 4JBM) [31,32]. 
Many structures of caspase-1 exist but they lack the CARD 
and so are not relevant to the mechanics of inflammasome 
assembly.
The isolated nature of the majority of these structures 
means that they can only provide a limited insight into 
the mechanisms of inflammasome assembly and the 
nature of the intra-molecular contacts involved. Although 
the PYD and CARD structures do provide insight into the 
residues likely to form binding interfaces which can then 
be investigated by mutagenesis studies. Until the inherent 
problem of protein aggregation can be reliably overcome 
this remains a significant hurdle in meeting the challenge 
of obtaining structural insight in to the protein-protein 
complexes formed in the inflammasome. 
The structures of autoinhibited NLRC4 and AIM2 in 
complex with dsDNA have however been vital in helping 
our understanding of inflammasome regulation [29,32,32] 
(Figure 3). For example, NLRC4 is maintained in an inactive 
conformation through the formation of an ADP-dependent 
interaction between Helical Domain 2 and a single alpha 
helix in the NBD. Interactions between one surface of the 
NBD and the LRRs serve to lock the conformation, until 
it is presumably released following recognition of ligand 
by a NAIP protein and their subsequent interaction with 
NLRC4 [29] (Figure 3A). Meanwhile activation of AIM2 
by dsDNA involves direct interaction between the ligand 
and the HIN domain of the receptor [31,32] (Figure 3B). 
Interestingly short DNA sequences are lined up along the 
binding surfaces to potentially mimic a longer sequence 
and recreate the presence of major and minor grooves. 
This is important for inhibition of AIM2 signalling in the 
mouse via the action of the protein p202. Although p202 
competes with AIM2 to bind DNA, it arranges its HIN 
domains in a different orientation to AIM2 and could 
feasibly intercalate into the minor groove of AIM2-bound 
DNA to inhibit subsequent AIM2 oligomerisation and 
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inflammasome formation [32]. Interestingly the structure 
of the NLRP1 LRRs [30] suggests that muramyl dipeptide, 
a potential NLRP1 ligand, is not capable of binding the 
LRRs. Whether this is indicative of an alternative binding 
site, or suggests that muramyl dipeptide is not in fact an 
activating ligand for NLRP1 remains to be determined.
4  The rise of the filament
An interesting twist on the classical view of inflammasome 
assembly occurs through the recent association of ASC 
filament formation and inflammasome activation. Two 
concurrent studies published earlier this year in Cell 
both reported that ASC could form filamentous structures 
[25,33]. Cai and co-workers demonstrated that the PYD of 
ASC has biochemical and genetic properties suggestive 
of prion-like behaviour and the formation of protein 
filaments (Figure 4A). Furthermore these filaments of ASC 
PYD were able to catalyse native ASC to form filamentous 
aggregates [33]. Meanwhile, using recombinant proteins 
Lu and colleagues demonstrated that both the AIM2 and 
NLRP3 PYD domains can act as nucleation points to initiate 
the formation of ASC-PYD filaments. The AIM2 PYD alone 
was sufficient to mediate this effect, however, NLRP3 
mediated formation also required the NBD, suggesting 
that the process of NLRP3 NBD-mediated oligomerisaton 
plays an important role in the initiating steps that result 
in ASC-PYD filament formation, and that the precise 
mechanism of AIM2 and NLRP3 initiated inflammasome 
formation may differ [25]. 
Cryo-EM observations of the ASC-PYD filaments 
revealed a ring-like structure formed from three 
intertwined helical strands. The inner and outer diameters 
of this structure were about 2 and 9 nm respectively, much, 
much, smaller than the specks observed within cells, 
which appeared to be the result of filament aggregation. 
Formation of the filament could be disrupted by point 
mutations in residues predicted to mediate PYD-PYD 
interactions. In vitro reconstitution studies using fusion 
proteins of full-length ASC, the caspase-1 CARD, and the 
AIM2 PYD led to formation of star-like structures in which 
the caspase-1 CARD formed additional filaments extending 
outwards from a central focus of AIM2 and ASC (Figure 4B). 
EM of inflammasomes purified from THP1 cells, as well as 
immunogold EM of Cos-1 cells overexpressing ASC fused 
to eGFP resulted in the visualisation of large, relatively 
disordered filament containing structures [25]. 
Further support for the formation of aggregated 
fibres of ASC has been provided by back-to-back papers 
in Nature Immunology  from the laboratories of Pelegrin 
and Latz [34,35]. Whilst characterising the inflammatory 
nature of inflammasome components released into the 
extracellular space both groups visualised the formation 
of ASC fibrils. Specks formed from ASC-mCerulean and 
released from cells were also able to seed the formation 
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Figure 3: Inflammasome related structures. (A) The crystal structure of the NBD-LRR structure of NLRC4 (PDB 4KXF) in the autoinhibited con-
formation is shown, coloured by its subdomains: Red - NBD; Blue - Helical Domain 1; Yellow - Winged Helix Domain; Orange - Helical Domain 
2; Grey - LRR; Black - ADP. (B) Crystal structure of the AIM2 HIN200 domains (green) bound to dsDNA (blue) (PDB 3RN2).
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of ASC-mCherry specks in recipient cells in a manner 
analogous to prions [35]. Interestingly these works were 
able to utilise EM to visualise ASC filaments in wild-type 
macrophages as well as in cells over-expressing ASC 
[34,35]. The observation that ASC can form filaments is 
however not new and overexpression of full-length ASC, 
and both the ASC CARD and PYD domains, have all been 
shown previously to form filaments in COS-7 cells [36]. 
In addition reconciliation of the formation of PYD-only 
filaments in the context of full-length ASC is needed, as is 
consolidation with the reported essential requirement for 
the ASC CARD in mediating speck formation [19].
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Figure 4:  Helical filaments and the initiation of inflammasome formation. (A) Cylinder representation of the three membered helix formed by 
the ASC PYD (adapted from PDB 3J63). Each helical chain is coloured orange, green or blue. (B) Schematic organisation for an inflammasome 
formed from helical filaments (top) or as visualised endogenously (bottom). Inflammasome initiating receptors (red) act as a nucleation 
signal for speck formation. In overexpression systems this results in ASC filament formation (dark purple) and filamentous recruitment 
of caspases (light purple). With endogenous expression levels a concentric ring-like structure is formed. (C) Model for the formation of a 
CARMA1 CARD initiating helical structure mediated by the formation of a triple coiled-coil domain. Each CARMA1 protomer is coloured red, 
orange or blue. (D and E) Potential models for the formation of a helical PYD filaments by AIM2-like receptors. (D) HIN200 domains (blue) 
bind to DNA and allow the cooperative formation of a helical strand (yellow) around the DNA molecule (E) HIN200 domains from AIM2 or IFI16 
(cartoon) bind to DNA and allow the cooperative formation of a platform for helical extension (surface).
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4.1  A wider perspective on filament 
formation
The assembly of polymeric filaments which elute in 
the void volume during size exclusion purification is 
a common theme in recent studies of CARDs and PYDs. 
While structures based on the assembly of the Bcl-10 
(B-cell lymphoma/leukemia 10) CARD [37], the MAVS 
(Mitochondrial antiviral-signaling protein) CARD [38] and 
the ASC PYD [25] are all remarkably different, they are 
each reported to be built up of interactions resembling 
the Type I, II and III interactions seen in DD complexes 
[14,15]. Spontaneous filament formation is limited for the 
individual domains but polymerisation can be induced by 
the introduction of known upstream binding partners. 
This phenomenon has perhaps been best 
characterised in the case of the MAVS CARD, which can 
be induced to polymerise by the tandem CARDs (2CARD) 
from RIG-I (Retinoic acid inducible gene I). An initial 
crystallography study showed 2CARD forming a helical 
tetramer in the presence of ubiquitin and suggested that 
MAVS CARDs might polymerise by extending this helix 
[39]. The same group subsequently used a 2CARD-MAVS 
fusion construct to show the formation of a helical layer 
above 2CARD consisting of four MAVS CARDs [38]. In 
this case, the MAVS CARDs were mutated to allow their 
interaction with 2CARD but prevent filamentation. This 
study also produced an EM-derived structure of the MAVS 
filament which overlays well onto the RIG-I/MAVS crystal 
structure, suggesting that helix formation continues 
in the same manner as laid out by the initiator helix. 
The relationship between the RIG-I and MAVS CARDs 
provides the first structural evidence of an initiator helix 
forming and inducing filament formation along the same 
helical pattern. This concept gives rise to various lines of 
investigation regarding its relevance and application to 
other complexes based on death domain assemblies, as 
discussed below.
Polymerisation of the Bcl-10 CARD alone is limited 
but can be significantly enhanced by CARMA1 (CARD-
containing MAGUK protein 1), which residues at one end 
of nascent polymers [37]. Bcl-10 and CARMA1 interact 
via their CARDs but the monomeric CARMA1 CARD is in 
itself unable to induce Bcl-10 polymerisation. However, 
CARMA1 constructs including the coiled coil domains can 
form trimers or oligomers and these constructs are able 
to enhance Bcl-10 polymerisation [37]. With reference to 
the RIG-I/MAVS studies, a likely model is that CARMA1 
oligomerisation through its coiled coil domains allows the 
stable assembly of an initiator helix between its CARDs, 
which is extended by Bcl-10 CARDs (Figure 4C). 
Likewise, the ASC PYD alone shows limited 
polymerisation but this can be enhanced by using the 
AIM2 PYD or NLRP3 PYD-NBD as initiators ([25], see 
above). These models centre around the formation of a 
three-stranded helix built from ASC PYDs which interact in 
a similar way to classical death domain complexes. AIM2 
and NLRP3 act as nucleation points for ASC elongation, 
likely by forming initiator helices from their own PYDs. 
The CARDs of ASC are found on the outside of the helix and 
interact with the CARD of caspase-1, appearing to initiate 
filaments of caspase-1 CARDs, extending away from the 
ASC helix. This results in the activation of caspase-1 and 
the subsequent processing of IL-1β [25] (Figure 4B).
AIM2, like other AIM2-like receptors, is activated 
through the interaction of its HIN200 domain with dsDNA 
and a combination of dsDNA and AIM2 induced ASC 
polymerisation more efficiently than AIM2 alone [25]. 
The binding of the related AIM2-like receptor, gamma-
interferon-inducible protein 16 (IFI16), to dsDNA is a 
cooperative process where the DNA binding is dependent 
on the HIN200 domains while the cooperativity requires 
the PYD [40]. This has been explained by the formation 
of a signalling platform by the PYDs, which may resemble 
the ASC helix. The inner diameter of the ASC helix leaves 
open the possibilities that AIM2/IFI16 initiator helices 
may form in a bundle alongside the DNA molecule or 
around the DNA itself (Figure 4D & E). 
NLRP3 is autoinhibited by its LRR domain and removal 
of the LRR domain mimics receptor activation. As expected, 
∆LRR NLRP3 was better at inducing ASC polymerisation 
than full-length NLRP3 [25]. EM studies of NLRP1 [10] and 
NLRC4/NAIP [11] show that these NLRs have the capacity 
to form circular wheel-like oligomers, similar to the 
apoptosome structures  in which the central, nucleotide-
binding domains mediate oligomerisation of the receptors 
while the CARDs or PYDs form a so far uncharacterised 
structure on top of this ring. As mentioned above the 
NLRP1 and NAIP/NLRC4 structures contain different 
numbers of protomers (5-7 and 11 or 12 respectively) [10,11]. 
Similarly, the human apoptosome is heptameric [41] while 
its homologues from C. elegans [42] and D. melanogaster 
[43] appear to be octomeric (Figure 2A & B). In all of these 
cases, the instigation of signalling through the formation 
of an initiator helix at the centre of the ring structure offers 
a resolution that would allow variation in the oligomeric 
number of the receptor (Figure 5). 
The new-found role of ASC in forming filaments may 
shed light on its role in NLRC4 signalling. Previously ASC 
was seen as a simple linker that connected the PYD from 
an NLRP or AIM2-like receptor to the CARD of caspase-1. 
Its role was therefore unclear in the case of NLRC4, which 
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can already interact with caspase-1 through its CARD 
[19,44] but requires ASC for high levels of IL-1β processing 
[45,46]. The induced polymerisation of ASC by NLRC4 is a 
potential mechanism for the increased caspase-1 activity. 
In light of the seemingly common nature of filament 
formation it has recently been proposed that such 
filamentous structures represent a new paradigm in the 
formation of macromolecular signalling complexes [47]. 
However, regardless of how impressive these studies 
appear there remains the caveat that they are reliant on 
various combinations of protein overexpression, the use of 
recombinant fusion proteins, the presence of fluorescent 
tags, and protein purification or sample preparation 
approaches of varying severity. It remains unclear how 
exactly these may affect protein-protein interactions. 
Indeed proteins from the death domain superfamily are 
inherently prone to aggregation. The open-ended nature 
of the filaments described differs significantly from the 
helical structures of the PIDDosome and MyDDosome, in 
which the stoichiometry is well defined and the structural 
assembly finite [14,15]. Further investigation is needed 
to confirm whether these filaments are physiologically 
relevant or an artefact of the high levels of protein achieved 
in overexpression and recombinant systems.
4.2  The ultrastructure of the inflamamsome
The use of fluorescent ASC-fusion proteins or the 
incorporation of fluorescent caspase inhibitors and 
substrates has enabled visualisation of inflammasome 
speck formation to become a routine read out in cell-
based studies [48]. As well as providing a ready marker for 
Figure 5: Mechanisms of potential initiator helix formation. (A) Side view of the electron density map of the Apaf-1 apoptosome suggests 
a slight helical twist, which could undergo propagation. (B) Theoretical model of the nucleating inflammasome structure demonstrating 
the feasibility of the effector domains (CARDs or PYDs) forming a helical complex after NBD mediated oligomerisation.  In this heptameric 
conformation each protomer contributes an effector domain to a central initiator helix.
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inflammasome activation these techniques highlight the 
large size of the speck, with over-expressed fluorescent 
ASC-fusions routinely producing specks of up to two 
microns in diameter. The overall dimensions of a speck 
are not fixed, they presumably relate to, and are regulated 
by, the availability of ASC, and other components, within 
the cell. Consequently the higher the level of ASC, the 
bigger the speck can become. Specks originating from 
overexpression systems usually appear solid and will 
often be seen to have ‘hair-like’ protrusions which have 
been proposed to represent sites of active ASC recruitment 
[35]. This would correlate strongly with the EM-observed 
string-like blobs upon ASC overexpression and the 
proposed process of filament formation [25]. 
Although ASC fibrils have been reported in wild-
type cells [34,35] the visualisation of endogenous 
inflammasomes has on other occasions painted a slightly 
different picture. The first observations of ASC complexes 
by pre-embedding EM occurred prior to the discovery of 
the inflammasome [49]. HL-60 cells were cultured with 
retinoic acid to induce apoptosis and ASC clustering was 
observed at the periphery of the cells. These clusters had 
hollow centres. Early images of endogenous levels of ASC 
[50] also presented with hollow centres in contrast to the 
solid speckles and filament-like aggregates observed with 
overexpressed ASC [36]. More recently Man and colleagues 
have utilised Bayesian localisation super-resolution 
microscopy to visualise the endogenous inflammasomes 
formed in response to Salmonella infection [51].  Using 
both immunolabelling and fluorescent-labelled inhibitor 
of caspases staining they observed hollow ring-like 
structures, with maximum diameters of approximately 0.6 
to 0.7 microns. These inflammasome rings were organised 
in a concentric manner consisting of an outer ASC ring, 
a central NLR-containing ring consisting of both NLRC4 
and NLRP3, and an internal caspase containing ring. An 
organisation markedly different to the star-like filament 
conformation reported by EM [25] (Figure 4B) and one 
that raises questions regarding the potential differences 
in macromolecular structure formed under endogenous 
conditions, compared to those requiring enhanced levels 
of protein expression.
One must also consider the possibility that the 
inflammasome is capable of forming multiple functional 
structures within the cell. For example, both the wheel-
like apoptosome-like structures and the specks may 
exist as discrete entities within the cell and fulfil specific 
functional roles. To our knowledge the apoptosome has 
never been visualised in the cell in a manner analogous 
to the inflammasome, but the functional relevance of 
the structures observed has not been questioned. One 
possibility is that a helical wheel structure could act to 
nucleate speck formation. Alternatively, they may act as 
speck-independent platforms for caspase-1 activation 
and pro-IL-1β processing. Support for this latter theory 
is provided by the heightened production of IL-1β by 
macrophages of patients with cryopyrin-associated 
periodic syndromes due to activating mutations in NLRP3 
[50,52]. This increase occurs in the absence of both 
inflammasome stimulation and speck formation.
4.3  The inflammasome in the future
The speck has been described as being formed of 
numerous interwoven filaments forming a larger structure, 
analogous to a bird’s nest [53]. Following nucleation, the 
whole cellular complement of ASC appears to be drawn 
to the speck. As such, the ratio of nucleating centres to 
ASC molecules will determine the length of resulting 
filaments. Experiments in which the levels of ASC and 
receptor are varied would help provide confirmation of 
this theory as overexpression of ASC should yield longer 
filaments and overexpression of a receptor should result 
in shorter filaments. Of course other factors such as 
Pyrin-Only-Proteins may also affect the length of PYD-
driven filaments, and it will be interesting to see their 
influence evaluated through the development and use of 
Pyrin-Only-Protein knock out cells. The possibility that 
filaments of different length will associate to form distinct 
speck structures makes studies observing endogenous 
levels of protein especially valuable.
Assuming that the role of receptors is to initiate ASC 
filamentation for speck assembly, results in a number 
of interesting questions. For example, how much order 
or disorder is there in the formation of specks from 
filaments? What roles do the ASC PYD and CARD play in 
filamentation and inter-filament binding? Do receptors 
remain attached to extended filaments indefinitely or can 
they dissociate and initiate new filaments? 
Models of the speck will have to take into account 
the distinct spatial arrangement of different receptor and 
caspase proteins around the ASC ring. For example, Man 
et al. show that the NLRC4 and NLRP3 receptors in an 
endogenous speck form distinct regions [51]. Is this due to 
a difference in the way the receptors bind to ASC or is it due 
to sequential recruitment to the growing speck? Analysis 
of speck formation in real-time could revolutionise our 
understanding of the dynamics of speck formation.
Notwithstanding the recent advances in our 
understanding of the organisation, the composition, and the 
possible assembly mechanisms of the inflammasome there is 
much still to be addressed. For example our knowledge of both 
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the spatial and temporal pathways involved in inflammasome 
formation remains limited. Careful use of knock out cells 
and visualisation of the endogenous inflammasome could 
help address these. Meanwhile, further information about 
the composition and potential stoichiometric requirements 
of the inflammasome is needed. This could be addressed 
using mass spectroscopy as has recently been achieved 
in stoichiometric studies of the death-inducing signalling 
complex [54]. Whilst, we know that speck formation can be 
extremely rapid questions remain unanswered about the 
dynamics of protein recruitment and would benefit from the 
use of carefully kinetic experiments. Finally, we still need to 
resolve the reasons underpinning the different appearances 
of the inflammasome specks visualised to date. This may 
well require application of various technologies to multiple 
systems to look for consistency. Certainly applying the high-
resolution techniques used to visualise the endogenous 
inflammasome to overexpression systems could rapidly 
clarify whether or not the global architecture of endogenous 
and exogenous inflammasomes differs. This is an exciting 
time to be working in this research field and without question 
the future holds not only the answers to the current areas of 
uncertainty, but no doubt some more surprises too. 
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